Whitney Notaro | executive |
Scott Wagner | executive |
Karsten Voermann | executive |
Stephanie Davis | analyst |
Lisa Gill | analyst |
Charles Rhyee | analyst |
Michael Cherny | analyst |
Mitchell Ostrovsky | analyst |
Jailendra Singh | analyst |
Jian Li | analyst |
Allen Lutz | analyst |
Daniel Grosslight | analyst |
Craig Hettenbach | analyst |
Scott Schoenhaus | analyst |
Stanislav Berenshteyn | analyst |
Dylan Finley | analyst |
George Hill | analyst |
Eric Sheridan | analyst |
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2023 Earnings Call.
As a reminder, today's conference call is being recorded.
I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.